CAMERON HAMMACK: Open Payments
NPI 1518343276 · MADISONVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 18 payments from 8 companies in 2025. Trend: 2023 $167 · 2024 $197 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| Axsome Therapeutics, Inc. | 4 | $89 |
| ABBVIE INC. | 2 | $44 |
| Exact Sciences Corporation | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 2 | $18 |
| Lilly USA, LLC | 1 | $14 |
Products named: REXULTI, Auvelity, VRAYLAR, Cologuard Collection Kit, FANAPT, TRELEGY ELLIPTA, VOQUEZNA, MOUNJARO.
Industry payments across KY — which companies pay providers there.
